Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol ST6GALNAC2 contributors: mct - updated : 05-03-2024
HGNC name ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
HGNC id 10867
EXPRESSION
Type widely
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestiveesophagus   highly
Endocrinethyroid   highly
Hearing/Equilibriumear   highly
Skin/Tegumentskin   highly
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
the L- and S- sialylmotifs
HOMOLOGY
Homologene
FAMILY
CATEGORY enzyme
SUBCELLULAR LOCALIZATION extracellular
    intracellular
intracellular,cytoplasm,organelle,mitochondria
intracellular,cytoplasm,organelle,membrane
intracellular,cytoplasm,organelle,Golgi
basic FUNCTION
  • catalyzing the synthesis of O-glycans
  • catalyzing the synthesis of O-glycans and the formation of mucin-related antigens in breast cancers
  • is a breast cancer metastasis suppressor
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • potential genetic interactions of C1GALT1 and ST6GALNAC2 variants influence IgA1 O-glycosylation
  • reduced sialylation of serum IgA1 may result likely from decreased expression of ST6GALNAC2
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --low  
    in breast cancer
    tumoral     --over  
    in estrogen receptor-negative breast cancers significantly correlates with reduced frequency of metastatic events and improved survival
    Susceptibility to IgA nephropathy
    Variant & Polymorphism other functional regulatory variant that may contribute to the genetic susceptibility in desialylation of IgA1 molecules causative pathogenesis of IgA nephropathy
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS